Skip to content
StockMarketAgent
Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

ACHV stock hub

Achieve Life Sciences, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

ACHVis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
277.4M
NASDAQ
Market data

Live price

Current market quote for this ticker.

Current price
ACHV
In the news

Latest news · ACHV

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 12.3P50 18.4P75 33.1
Trailing P/En/a
P25 14.9P50 23.2P75 38.5
ROE-257.7
P25 -105.6P50 -46.5P75 -3.1
ROIC-101.9
P25 -63.1P50 -27.3P75 0.5
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All ACHV market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
180
Groups with data
11
Currency
USD
Showing 180 of 180 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

23
MetricValue
Cik
0000949858
Company name
Achieve Life Sciences, Inc.
Country
United States
Country code
US
Cusip
004468203
Employees
28
Employees Change
3%
Employees Change Percent
12
Enterprise value
$255.9M
Exchange
NASDAQ
Financial currency
USD
First seen
2026-05-09
Industry
Biotechnology
Isin
US0044685008
Last refreshed
2026-05-10
Market cap
$277.4M
Market cap category
Micro-Cap
Price
$5.21
Price currency
USD
Sector
Healthcare
Sic
2835
Symbol
ACHV
Website
https://www.achievelifesciences.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

3
MetricValue
Earnings Yield
-19.7%
FCF yield
-17.83%
P/B ratio
12.89x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

9
MetricValue
Net Income
$-54.6M
Net Income Growth Years
0%
Profit Per Employee
$-2M
ROA
-85.3
Roa5y
-70.29
ROCE
-167.8
ROE
-257.7
Roe5y
-374.3
ROIC
-101.9

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

6
MetricValue
Cagr1y
119.03%
Cagr3y
-15.74%
Cagr5y
-12.37%
EPS Growth Quarters
2
EPS Growth Years
0
Revenue Growth Years
0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

18
MetricValue
Assets
$41.8M
Cash
$36.4M
Current Assets
$39.9M
Current Liabilities
$9.1M
Debt
$15M
Debt Equity
$0.7
Equity
$21.5M
Interest Coverage
-67.01
Liabilities
$20.3M
Long Term Assets
$1.9M
Long Term Liabilities
$11.2M
Net Cash
$21.4M
Net Cash By Market Cap
$7.73
Net Cash Growth
-12.1%
Net Debt Equity
$-1
Tangible Book Value
$19.7M
Tangible Book Value Per Share
$0.37
WACC
16.01

Liquidity

Current-asset coverage and working-capital efficiency metrics.

4
MetricValue
Current ratio
4.39
Net Working Capital
$-1.8M
Quick ratio
4.01
Working Capital
$30.8M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

2
MetricValue
Buyback Yield
-35.93%
Dividend Yield
0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

40
MetricValue
1Y total return
118.91%
200-day SMA
3.98
3Y total return
-40.18%
50-day SMA
3.98
50-day SMA vs 200-day SMA
50under200
5Y total return
-48.31%
All Time High
1,053.7
All Time High Change
-99.51%
All Time High Date
2017-08-02
All Time Low
1.84
All Time Low Change
183.15%
All Time Low Date
2025-04-09
ATR
0.35
Beta
2.25
Beta1y
4.21
Beta2y
2.62
Ch YTD
4.83
High
5.35
High52
6.03
High52 Date
2026-01-16
High52ch
-13.53%
Low
4.74
Low52
2
Low52 Date
2025-06-27
Low52ch
160.5%
Ma50ch
31.07%
Premarket Change Percent
1.25
Premarket Price
$4.85
Premarket Volume
469
Price vs 200-day SMA
31.04%
RSI
70.08
RSI Monthly
50.92
RSI Weekly
56.74
Sharpe ratio
1.24x
Sortino ratio
2.03
Total Return
-35.93%
Tr YTD
4.83
Tr1m
62.81%
Tr1w
18.95%
Tr3m
22.59%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

6
MetricValue
Analyst Count
3
Analyst Ratings
Strong Buy
Earnings EPS Estimate
$-0.3
Operating Income
$-54.9M
Price target
$14.67
Price Target Change
$182

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

11
MetricValue
Float
26,633,990%
Float Percent
50.03%
Net Borrowing
5,000,000
Shares Insiders
4.91%
Shares Institutions
50.87%
Shares Out
53,239,988
Shares Qo Q
4.43%
Shares Yo Y
35.93%
Short Float
25.7%
Short Ratio
7.74
Short Shares
12.86

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

58
MetricValue
Adjusted FCF
$-58.2M
Average Volume
1,906,938.35x
Bv Per Share
0.4
CAPEX
$-3,000
Ch1m
62.81
Ch1w
18.95
Ch1y
118.9
Ch3m
22.59
Ch3y
-40.18
Ch5y
-48.31
Ch6m
13.51
Change
8.77%
Change From Open
8.32
Close
4.79
Days Gap
0.42
Depreciation Amortization
228,000
Dollar Volume
9,167,990.1
Earnings Date
2026-05-12
Earnings Time
bmo
EBIT
$-54.9M
EBITDA
$-54.7M
EPS
$-1.25
F Score
1
FCF
$-49.5M
FCF EV Yield
-19.33x
FCF Per Share
$-0.93
Financing CF
51,527,000
Fiscal Year End
December
Goodwill
1,034,000
Investing CF
6,111,000
Is Primary Listing
1
Is Spac
No
Last Earnings Date
2026-03-24
Last Report Date
2025-12-31
Last Split Date
2020-07-31
Last Split Type
Reverse
Last10k Filing Date
2026-03-24
Ma150
4.35
Ma150ch
19.69%
Ma20
4.32
Ma20ch
20.6%
Net CF
8,176,000
Next Earnings Date
2026-05-12
Open
4.81
Optionable
Yes
Position In Range
77.05
Post Close
5.21
Postmarket Change Percent
0.19
Postmarket Price
$5.22
Ppne
67,000
Pre Close
4.79
Price Date
2026-05-08
Ptbv Ratio
14.06
Relative Volume
0.92x
Share Based Comp
8,761,000
Tr6m
13.51%
Us State
Washington
Volume
1,759,691
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does ACHV pay a dividend?

Capital-return profile for this ticker.

Performance

ACHV stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+118.9%
S&P 500 1Y: n/a
3Y total return
-40.2%
S&P 500 3Y: n/a
5Y total return
-48.3%
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns ACHV?

Insider, institutional, and short-interest positioning.

Institutional ownership
+50.9%
Float: +50.0% of shares outstanding
Insider ownership
+4.9%
Stake held by company insiders. Higher generally signals alignment.
Short interest
+25.7%
7.7 days to cover
Y/Y dilution
+35.9%
Negative means the company is buying back shares.
Technical

ACHV momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
70.1
Above 70: short-term overbought
Price vs 200-day MA
+31.0%
50/200-day relationship not available
Beta (5Y)
2.25
More volatile than the market
Sharpe ratio
1.24
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About ACHV

Hub-level FAQ points readers to the deeper analysis pages.

What is the current ACHV stock rating?

Achieve Life Sciences, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full ACHV analysis?

The full report lives at /stocks/ACHV/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for ACHV?

The latest report frames ACHV around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the ACHV page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.